These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2573989)

  • 41. In vitro suppression of anti-TSH receptor antibody by autologous anti-idiotypic antibody in patients with Graves' disease.
    Balázs C; Molnár I
    Acta Microbiol Immunol Hung; 1995; 42(2):163-9. PubMed ID: 7551709
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changes in thyroid-stimulating antibody activity in Graves' disease treated with antithyroid drug and its relationship to relapse: a prospective study.
    Teng CS; Yeung RT
    J Clin Endocrinol Metab; 1980 Jan; 50(1):144-7. PubMed ID: 6892512
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-bovine TSH antibodies in patients with Graves' disease and primary myxedema.
    Cho BY; Shong YK; Lee HK; Koh CS; Min HK
    Thyroidology; 1989 Apr; 1(1):31-7. PubMed ID: 2484905
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Binding, stimulating and blocking TSH receptor antibodies to the thyrotropin receptor as predictors of relapse of Graves' disease after withdrawal of antithyroid treatment.
    Quadbeck B; Hoermann R; Hahn S; Roggenbuck U; Mann K; Janssen OE
    Horm Metab Res; 2005 Dec; 37(12):745-50. PubMed ID: 16372228
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera.
    Rotella CM; Zonefrati R; Toccafondi R; Valente WA; Kohn LD
    J Clin Endocrinol Metab; 1986 Feb; 62(2):357-67. PubMed ID: 2416769
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heterogeneity of Graves' immunoglobulin G: comparison of thyrotropin receptor antibodies in serum and in culture supernatants of lymphocytes transformed by Epstein-Barr virus infection.
    Yokoyama N; Izumi M; Katamine S; Nagataki S
    J Clin Endocrinol Metab; 1987 Feb; 64(2):215-8. PubMed ID: 2878934
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased activated T-lymphocytes and normal thyrotropin receptor antibody levels in Graves' disease in long-term remission.
    Peakman M; Hussain M; Cundy T; Vergani D
    J Clin Lab Immunol; 1989 Sep; 30(1):1-5. PubMed ID: 2577115
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Individual outcome monitoring of TSH receptor antibody level for predicting the prognosis of Graves' disease].
    Rink T; Holle LH; Schroth HJ; Garth H
    Nuklearmedizin; 1998 May; 37(3):90-4. PubMed ID: 9604228
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods.
    Morris JC; Hay ID; Nelson RE; Jiang NS
    Mayo Clin Proc; 1988 Jul; 63(7):707-17. PubMed ID: 2898572
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
    Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
    J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relapse of Graves' disease after successful outcome of antithyroid drug therapy: results of a prospective randomized study on the use of levothyroxine.
    Hoermann R; Quadbeck B; Roggenbuck U; Szabolcs I; Pfeilschifter J; Meng W; Reschke K; Hackenberg K; Dettmann J; Prehn B; Hirche H; Mann K;
    Thyroid; 2002 Dec; 12(12):1119-28. PubMed ID: 12593726
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thyrotropin receptor autoantibodies are associated with continued thyrotropin suppression in treated euthyroid Graves' disease patients.
    Brokken LJ; Wiersinga WM; Prummel MF
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4135-8. PubMed ID: 12970276
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An analysis of thyrotrophin receptor binding and thyroid stimulating activities in a series of Graves' sera.
    Creagh F; Teece M; Williams S; Didcote S; Perkins W; Hashim F; Rees Smith B
    Clin Endocrinol (Oxf); 1985 Oct; 23(4):395-404. PubMed ID: 2998648
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical validity of intercellular adhesion molecule-1 (ICAM-1) and TSH receptor antibodies in sera from patients with Graves' disease.
    Massart C; Sonnet E; Gibassier J; Maugendre D; Genetet B
    Clin Chim Acta; 1997 Sep; 265(2):157-68. PubMed ID: 9385458
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thyrotropin receptor antibodies in hypothyroid Graves' disease.
    Kasagi K; Hidaka A; Nakamura H; Takeuchi R; Misaki T; Iida Y; Konishi J
    J Clin Endocrinol Metab; 1993 Feb; 76(2):504-8. PubMed ID: 8094394
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Graves' disease: immunological and immunogenetic indicators of relapse.
    de Bruin TW; Bolk JH; Bussemaker JK; Stijnen T; Schreuder GM; de Vries RR; van der Heide D
    Br Med J (Clin Res Ed); 1988 May; 296(6632):1292-5. PubMed ID: 3133054
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Can thyroid stimulating hormone levels by TSH (IRMA) predict relapse of thyrotoxicosis following carbimazole treatment?
    Wilson R; Semple CG; Reid AM; Glen AC; McKillop JH; Thomson JA
    Postgrad Med J; 1987 Sep; 63(743):755-6. PubMed ID: 3444799
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Juvenile Graves disease: usefulness and limitations of thyrotropin receptor antibody determinations.
    Foley TP; White C; New A
    J Pediatr; 1987 Mar; 110(3):378-86. PubMed ID: 2880956
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic value of suppressed thyrotropin level and positive thyrotropin-receptor antibody activity in Graves' disease with long-lasting clinical remission.
    Heshmati HM; Chevalier A; Gharib H; Clerc J; Boutteville C; Izembart M
    Endocr Pract; 1997; 3(3):113-7. PubMed ID: 15251469
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prediction of relapse in hyperthyroid Graves' disease.
    McGregor AM; Smith BR; Hall R; Petersen MM; Miller M; Dewar PJ
    Lancet; 1980 May; 1(8178):1101-3. PubMed ID: 6103438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.